Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Galvanize Therapeutics Inc. currently manages 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. This portfolio is concentrated in 1 art unit, suggesting a narrow technical focus for their current patent applications. The 2 pending office actions are distributed across 2 distinct examiners, indicating that each examiner is handling exactly 1 matter for the company. This 1 to 1 ratio between actions and examiners suggests a lack of examiner concentration in the current pipeline.
ZINK, AMANDA L is identified as the busiest examiner for this portfolio, currently overseeing 1 pending office action. Because the total of 2 pending office actions is split between 2 distinct examiners, no single examiner holds a majority of the active workload. This distribution across 1 art unit means the company is likely interacting with a specific group of supervisory patent examiners despite the involvement of multiple individual examiners. Practitioners should note that the 2 pending office actions represent the entirety of the current examiner interactions for this entity.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZINK, AMANDA L | 1 | 85.2% | +3.1% |
| FOWLER, DANIEL WAYNE | 1 | 72.7% | +12.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19224643 | METHODS, APPARATUSES, AND SYSTEMS FOR THE TREATMENT OF PULMONARY DISORDERS | ZINK, AMANDA L | — |
| 18792495 | CONTROLLED LESION AND IMMUNE RESPONSE TO PULSED ELECTRIC FIELD THERAPY | FOWLER, DANIEL WAYNE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18792495 | CONTROLLED LESION AND IMMUNE RESPONSE TO PULSED ELECTRIC FIELD THERAPY | FOWLER, DANIEL WAYNE | — |
| Art Unit | Apps |
|---|---|
| 3794 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19224643 | METHODS, APPARATUSES, AND SYSTEMS FOR THE TREATMENT OF PULMONARY DISORDERS | ZINK, AMANDA L | 3794 | §102§103 | Non-Final OA | — | Pending | May 30, 2025 |
| 18792495 | CONTROLLED LESION AND IMMUNE RESPONSE TO PULSED ELECTRIC FIELD THERAPY | FOWLER, DANIEL WAYNE | 3794 | §102§112 | Non-Final OA | — | Pending | Aug 01, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial